慢性肢体威胁性缺血住院患者的疼痛管理:一项多中心横断面研究
结果显示中重度疼痛(≥5/10)占80.7%,尽管对乙酰氨基酚和强阿片类药物广泛使用,39.6%患者仍报告镇痛不足,疼痛显著干扰活动、情绪、行走和睡眠。
要点
- CLTI住院患者中80.7%存在中重度疼痛(≥5/10),当前疼痛中位5/10,过去24小时最痛中位8/10。
- 尽管93.7%用对乙酰氨基酚、50%用吗啡、38.9%用羟考酮,39.6%仍镇痛不足。
- 疼痛显著干扰一般活动(76.7%)、情绪(67.0%)、行走能力(83.5%)和睡眠(73.6%)。
核心结论
- CLTI住院患者的疼痛管理不充分,对大多数患者的生活几乎各个方面产生负面影响。
- 疼痛控制不佳可能源于对缺血性疼痛机制的研究和认识不足,亟需建立针对缺血性疼痛的循证镇痛策略。
研究设计与样本
- 多中心横断面研究,在2所教学医院开展,纳入以CLTI为主要诊断的血管外科住院患者。
- 使用简明疼痛评估量表(Brief Pain Inventory)评估疼痛严重程度及对7个日常功能领域的影响,并收集镇痛方案及近期或计划血运重建或截肢情况。
主要发现
- 当前疼痛中位数为5/10(IQR 3-7.5),过去24小时最痛中位数为8/10(IQR 5-10)。
- 80.7%的患者报告中度至重度疼痛(≥5/10)。
- 39.6%的患者报告镇痛不足。
- 疼痛干扰一般活动(76.7%)、情绪(67.0%)、行走能力(83.5%)和睡眠(73.6%)。
- 在严重疼痛(≥7/10)患者中,14.2%未记录使用强阿片类药物;总队列中6.3%未接受对乙酰氨基酚。
临床怎么用
- 对CLTI住院患者应使用简明疼痛评估量表等工具系统评估疼痛严重程度及功能影响,而非仅依据主诉。
- 即使已使用对乙酰氨基酚和强阿片类药物,仍需警惕镇痛不足,需个体化调整镇痛方案。
- 关注疼痛对活动、情绪、行走和睡眠的干扰,将功能改善纳入疼痛管理目标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic limb-threatening ischemia (CLTI) is characterized, in part, by persistent ischemic rest pain lasting for 2 weeks or more. Pain management in these patients remains challenging. The World Health Organization analgesic ladder, developed mainly from research on oncological pain, may lead to suboptimal pain relief and significant side effects in vascular patients. The objective of the study was to evaluate effective pain management in hospitalized patients with CLTI using the Brief Pain Inventory score. METHODS: A cross-sectional study was conducted across 2 teaching hospitals on vascular patients with a primary diagnosis of CLTI. Data collected included Brief Pain Inventory, which measures a patient's pain severity and its impact on daily function across 7 domains. Further data were also collected on analgesia regimens and their subsequent impact on overall pain scores, as well as whether the patient had undergone a recent or planned revascularization or amputation. RESULTS: One hundred four patients (median age 69 years [interquartile range (IQR) 60-76]; 64.4% male) were included. The median current pain was 5/10 (IQR 3-7.5), and the worst pain in the previous 24 hours was 8/10 (IQR 5-10). Moderate to severe pain (≥5/10) was reported by 80.7% of patients. Despite the widespread use of paracetamol (93.7%) and strong opioids (morphine 50%; oxycodone 38.9%), 39.6% reported inadequate pain relief. Pain interfered with general activity (76.7%), mood (67.0%), mobility (83.5%), and sleep (73.6%) in the majority of patients. Among patients with severe pain (≥7/10), 14.2% had no strong opioid documented and 6.3% of the total cohort received no paracetamol. CONCLUSION: This study demonstrates that pain management for inpatients with CLTI is inadequate and negatively affects nearly all aspects of life for most patients. This is likely due to a lack of research and understanding of the mechanisms of ischemic pain. Further research is urgently needed to establish evidence-based analgesic strategies specific to ischemic pain.
引用
- Davies H, Boalot A, Mountain T, et al. Pain Management in Chronic Limb-Threatening Ischemia: A Multicentre Cross-Sectional Study. Ann Vasc Surg. 2026. PMID: 41690385. doi:10.1016/j.avsg.2026.02.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。